Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin sodium Warfarin sodium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬1. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin potassium Warfarin potassium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬1. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin Warfarin 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬1. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 1件: F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 10件: 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬4. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F2 1件: F2 💬Complement and coagulation cascades
|
Dabigatran Dabigatran 💬Complement and coagulation cascades
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬5. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
F2 1件: F2 💬Coronavirus disease
|
Dabigatran Dabigatran 💬Coronavirus disease
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬6. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin sodium Warfarin sodium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬7. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin potassium Warfarin potassium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬7. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin Warfarin 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬7. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin sodium Warfarin sodium 💬Hepatocellular carcinoma
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬10. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin potassium Warfarin potassium 💬Hepatocellular carcinoma
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬10. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin Warfarin 💬Hepatocellular carcinoma
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬10. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
F2 1件: F2 💬Neuroactive ligand-receptor interaction
|
Dabigatran Dabigatran 💬Neuroactive ligand-receptor interaction
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬13. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
F2 1件: F2 💬Pathogenic Escherichia coli infection
|
Dabigatran Dabigatran 💬Pathogenic Escherichia coli infection
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬14. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
F2 1件: F2 💬Pathways in cancer
|
Dabigatran Dabigatran 💬Pathways in cancer
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬15. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
NQO1 1件: NQO1 💬Pathways in cancer
|
Warfarin sodium Warfarin sodium 💬Pathways in cancer
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
NQO1 1件: NQO1 💬Pathways in cancer
|
Warfarin potassium Warfarin potassium 💬Pathways in cancer
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
NQO1 1件: NQO1 💬Pathways in cancer
|
Warfarin Warfarin 💬Pathways in cancer
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
F2 1件: F2 💬Phospholipase D signaling pathway
|
Dabigatran Dabigatran 💬Phospholipase D signaling pathway
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬19. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
F2 1件: F2 💬Platelet activation
|
Dabigatran Dabigatran 💬Platelet activation
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬20. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
F2 1件: F2 💬Regulation of actin cytoskeleton
|
Dabigatran Dabigatran 💬Regulation of actin cytoskeleton
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬21. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 2 drugs (DrugBank) and 17 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin sodium Warfarin sodium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 2 drugs (DrugBank) and 17 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin potassium Warfarin potassium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 2 drugs (DrugBank) and 17 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin Warfarin 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 15件: 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
Chemical carcinogenesis - reactive oxygen species
24 genes, 37 drugs (DrugBank) and 53 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Ubiquinone and other terpenoid-quinone biosynthesis
3 genes, 2 drugs (DrugBank) and 17 diseases